Időskori makuladegeneráció: vizsgálatok itt: Kanada
10 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peoplePhase 2 Study of ADX-038 in Participants With Geographic Atrophy
- Where
- Edmonton, London, Ottawa, Toronto, Vancouver
- Életkor
- 60 év and over
- People
- 240 worldwide
- Run by
- ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- London, Ottawa
- Életkor
- 50 év and over
- People
- 272 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00 - 3. fázisTaking peopleA Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Where
- Ottawa, Québec
- Életkor
- 50 év to 85 év
- People
- 975 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00 - No phaseNot yet taking people in KanadaMacuMira Microcurrent Stimulation for Dark Adaptation in Dry Age-Related Macular Degeneration
- Where
- Newmarket, Scarborough Village, Vaughan
- Életkor
- 18 év and over
- People
- 50
- Run by
- Clarity Eye Institute
See details and how to joinNCT07917715 - 2/3. fázisBefejeződöttA Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Where
- Edmonton
- Életkor
- 60 év and over
- People
- 274 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00 - 3. fázisTaking peopleStudy to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Where
- Ottawa
- Életkor
- 50 év and over
- People
- 561 worldwide
- Run by
- AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00 - 2. fázisTaking peopleStudy to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Where
- Boisbriand, London, Toronto
- Életkor
- 55 év and over
- People
- 324 worldwide
- Run by
- ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00 - 1/2. fázisTaking peopleA Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- Ottawa
- Életkor
- 55 év to 80 év
- People
- 62 worldwide
- Run by
- Kriya Therapeutics, Inc.
See details and how to joinNCT06765980 - No phaseTaking peopleLearning Study: Improving Vision in Adults With Macular Degeneration
- Where
- Waterloo
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- University of Waterloo
See details and how to joinNCT04762368 - 3. fázisNot yet taking people in KanadaHigh Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 180
- Run by
- Clinique de Retine de l'est
See details and how to joinNCT07129239